SGLT2 Inhibitors and EMPA-KIDNEY: Revolutionizing the management of CKD

Jadoul, Michel
(2024) EMPA-KIDNEY - Completing the role of SGLT2i on CKD treatment with broad population patients — Location: Ho Chi Minh City, Vietnam (24.November.2024)

Files

No attached file found for this publication.

Details

Authors
  • Jadoul, MichelUCLouvain
    Author
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Jadoul, M. (2024). SGLT2 Inhibitors and EMPA-KIDNEY: Revolutionizing the management of CKD. EMPA-KIDNEY - Completing the role of SGLT2i on CKD treatment with broad population patients, Ho Chi Minh City, Vietnam. https://hdl.handle.net/2078.5/240037